Patient Support Hub

Medical Disclaimer: The following information is for educational purposes only. Always consult a board-certified dermatologist before starting a new prescription regimen. For decades, the standard treatment for inflammatory skin diseases relied on corticosteroids and calcineurin inhibitors. While these are effective, long-term use often leads to skin thinning (atrophy) or a plateau in efficacy for chronic cases. The introduction of topical Janus kinase (JAK) inhibitors has changed this landscape. By targeting inflammation at the molecular level, these non-steroidal creams provide a precise alternative for patients with vitiligo, atopic dermatitis, and chronic hand eczema. What is a Topical Janus Kinase Inhibitor? A topical JAK inhibitor is a medication applied to the skin to block specific enzymes: JAK1, JAK2, JAK3, and Tyrosine Kinase 2 (TYK2). These enzymes function as signaling "gatekeepers" that tell the immune system to produce inflammation. When these pathways become...